Enhance and accelerate your early stage research with trusted and comprehensive intelligence from Thomson Reuters.

Start your free trial in just two simple steps.

Get your FREE trial

Enrich your discovery science with market leading, manually curated scientific intelligence. Systems Biology, Preclinical, Biomarkers, Chemistry, Biology, and Pharmacology - and everything in between. Covered from the perspective that matters most – yours.
Customer Feedback
Customer Feedback

Annette Bakker, Chief Scientific Officer from CTF, explains the reasons why she likes to work with Thomson Reuters. Currently using MetaCore™ to identify disease treatment options.

Live & Recorded Training

Attend one of our regularly scheduled webinar training sessions for overviews of features, tools, and content – find the schedule here

Free Pathway Maps

Search or browse through a wide range of proprietary multi-step canonical pathway maps here.

Featured News

The latest news from Life Sciences Research
The future of COPD treatment

The future of COPD treatment

Our research shows greater focus on preventative therapies

Translational Medicine

Translational Medicine

Supplement-Size Doses of Antioxidants Hasten Lung Cancer Progression

Tet Proteins Erase Epigenetic Marks

Tet Proteins Erase Epigenetic Marks

It is (reasonably) common knowledge that DNA is written in a simple four-letter code: ACTG. Too simple, actually.

Blog Highlights

Read our latest blog posts

Innovation Yields New Therapies for MDR Infections, Hepatitis C and Hemophilia in 2014

2014 was another good year for the pharmaceutical and biotech industry, as evidenced by the introduction of 55 new products worldwide (as of December 23, ...

New Labeling Rule Will Help, but Can’t Compensate for Scant Information on Drug Safety in Pregnancy

What is perceived as “safe” during pregnancy often varies among women and healthcare providers, many of whom rely on prescription drug labels to decide whether ...

New Sunscreen Approval—Why So Complicated?

Topically-applied sunscreen product use is a billion-dollar industry. The use of these products over the last 40 years has changed dramatically from a “niche” market ...

Whitepapers & Publications

View our recent whitepapers and publications

BioMarker White Paper

Biomarkers: An indispensible addition to the drug development toolkit


Latest on Twitter

Latest on Linked In